Pages that link to "Q42280089"
Jump to navigation
Jump to search
The following pages link to Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis (Q42280089):
Displaying 50 items.
- Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostate cancer (Q24310439) (← links)
- Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma (Q24656802) (← links)
- Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis (Q24669710) (← links)
- Expression of vascular endothelial growth factor (VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma (Q24805206) (← links)
- Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis (Q28200101) (← links)
- Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway (Q28216853) (← links)
- Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element (Q28512426) (← links)
- Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis (Q33202253) (← links)
- Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice (Q33326045) (← links)
- Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors (Q33509896) (← links)
- Current biology of VEGF-B and VEGF-C. (Q33796264) (← links)
- Impact of lymph node micrometastasis in hilar bile duct carcinoma patients (Q33868494) (← links)
- Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway (Q34003819) (← links)
- Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma (Q34017710) (← links)
- Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. (Q34066152) (← links)
- Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease (Q34091198) (← links)
- Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. (Q34130552) (← links)
- Effect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells (Q34141566) (← links)
- Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma (Q34334079) (← links)
- Lymphatic vessels as targets of tumor therapy? (Q34372169) (← links)
- Lymphatic function, lymphangiogenesis, and cancer metastasis (Q34398724) (← links)
- Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer (Q34534087) (← links)
- Lymphatic dissemination of tumour cells and the formation of micrometastases (Q34571762) (← links)
- Lymphangiogenesis and cancer metastasis (Q34770288) (← links)
- Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma (Q35041319) (← links)
- Regulating the angiogenic balance in tissues (Q35062979) (← links)
- Insights into the mechanisms of lymph node metastasis (Q35181938) (← links)
- miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells (Q35557027) (← links)
- Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate (Q35570343) (← links)
- Prognostic Significance of VEGF-C Expression in Patients with Breast Cancer: A Meta-Analysis (Q35670023) (← links)
- Crosstalk between angiogenesis and lymphangiogenesis in tumor progression (Q35730252) (← links)
- Vasohibin-1 suppresses colon cancer (Q35781453) (← links)
- Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesis (Q35995835) (← links)
- The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan (Q35999161) (← links)
- Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2. (Q36014743) (← links)
- Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment (Q36357356) (← links)
- Current status and perspective of antiangiogenic therapy for cancer: urinary cancer (Q36452714) (← links)
- Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers (Q36519259) (← links)
- Role of vascular endothelial growth factor in prostate cancer. (Q36563885) (← links)
- The role of the VEGF-C/VEGFRs axis in tumor progression and therapy (Q36589860) (← links)
- Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. (Q36611320) (← links)
- The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer (Q36611550) (← links)
- Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer (Q36623053) (← links)
- The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer (Q36623444) (← links)
- Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues (Q36642309) (← links)
- A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer (Q36646055) (← links)
- Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients (Q36695451) (← links)
- Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers (Q36695475) (← links)
- Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer (Q36735345) (← links)
- Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients (Q37071863) (← links)